Late-window IV tenecteplase for acute ischemic stroke
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This registry tracks how well tenecteplase (a clot-busting medication) works when given more than 4.5 hours after a stroke starts. Researchers want to learn if treating strokes this late can still help patients recover.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with an acute ischemic stroke (a clot blocking blood flow to your brain)
- More than 4.5 hours have passed since you last felt normal, even if you didn't see the stroke happen
- You received intravenous tenecteplase (a clot-busting drug injected into your vein)
- You can provide written informed consent or have an authorized representative do so
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks patients who receive IV thrombolysis (a clot-busting medication injected into the vein) for acute ischemic stroke more than 4.5 hours after their stroke started. Researchers want to learn whether this extended-window treatment can still help patients recover when given outside the typical time window.
This trial tests a new medication called rhTNK-tPA for treating acute ischemic stroke (a clot in the brain) up to 24 hours after symptom onset. The study uses simplified imaging to determine eligibility and aims to help patients recover better outcomes.
This trial tests if the clot-busting drug tenecteplase is safe and effective for people having an ischemic stroke who have recently taken blood thinners (DOACs). If you qualify, you may receive either tenecteplase or a placebo within 24 hours of your last known well time.
This trial tests a clot-dissolving medicine called tenecteplase for people who had a stroke more than 4.5 hours ago. It may help you recover if given later than usual.
This trial tests if the clot-busting drug tenecteplase can help people with a moderate to severe stroke when given 24 to 72 hours after symptoms began. It aims to see if this later treatment window can improve recovery and reduce disability.
This trial tests a clot-busting drug called tenecteplase for people who had a stroke affecting the back part of the brain (posterior circulation). It may be an option if you can get treatment between 4.5 and 24 hours after symptoms started.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.